Literature DB >> 13680581

Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report.

Dennis D Dykstra1, Jon Pryor, Gary Goldish.   

Abstract

We describe a patient with multiple sclerosis (MS) who had detrusor hyperreflexia that was not responsive to oral medications or clean intermittent catheterization. This patient was successfully treated with 2 separate injections of botulinum toxin type B into the bladder. The results of the treatment lasted 4 months and there were no side effects. A cystometrogram (CMG) done before the botulinum toxin type B injections showed significant detrusor instability. A repeat CMG months later showed no detrusor instability. To our knowledge, this is the first reported successful use of botulinum toxin type B in a patient with detrusor hyperreflexia from MS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680581     DOI: 10.1016/s0003-9993(03)00202-8

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

1.  Long term effects of intra-articular botulinum toxin A for refractory joint pain.

Authors:  M L Mahowald; J A Singh; D Dykstra
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 2.  Botulinum toxin for the management of bladder dysfunction.

Authors:  Brigitte Schurch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  The symptomatic management of multiple sclerosis.

Authors:  Randall T Schapiro
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

4.  Treatment of overactive bladder with botulinum toxin type B: a pilot study.

Authors:  Dennis Dykstra; Al Enriquez; Michael Valley
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-25

Review 5.  The use of botulinum neurotoxin type A (BoNTA) in urology.

Authors:  A Apostolidis; C J Fowler
Journal:  J Neural Transm (Vienna)       Date:  2008-03-06       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.